| Cell line name |
PER-163 |
|---|
| Accession |
CVCL_W977 |
|---|
| Resource Identification Initiative |
To cite this cell line use: PER-163 (RRID:CVCL_W977) |
|---|
| Disease |
Childhood B acute lymphoblastic leukemia (NCIt: C9140)
Precursor B-cell acute lymphoblastic leukemia (ORDO: Orphanet_99860) |
|---|
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
|---|
| Originate from same individual |
CVCL_W976 ! PER-145
CVCL_W978 ! PER-164 |
|---|
| Sex of cell |
Male |
|---|
| Category |
Cancer cell line |
|---|
| Publications | PubMed=3472651
Kees U.R.
Resistance to 1-beta-D-arabinofuranosylcytosine after high-dose treatment childhood lymphoblastic leukemia: isolation of a drug resistant and a sensitive cell line.
Cancer Res. 47:3088-3091(1987) PubMed=2720661
Kees U.R., Ford J., Dawson V.M., Piall E.M., Aherne G.W.
Development of resistance to 1-beta-D-arabinofuranosylcytosine after high-dose treatment in childhood lymphoblastic leukemia: analysis of resistance mechanism in established cell lines.
Cancer Res. 49:3015-3019(1989) PubMed=7540895; DOI=10.1097/00001813-199504000-00015
Kees U.R., Avramis V.I.
Biochemical pharmacology and DNA methylation studies of arabinosyl 5-azacytidine and 5,6-dihydro-5-azacytidine in two human leukemia cell lines PER-145 and PER-163.
Anticancer Drugs 6:303-310(1995) |
|---|
| Cross-references |
|---|
| Encyclopedic resources |
Wikidata; Q54947176
|
|---|
| Entry history |
|---|
| Entry creation | 17-Jul-2014 |
|---|
| Last entry update | 21-Mar-2023 |
|---|
| Version number | 6 |
|---|